Home | Publications | Research (R&D) | Clinical Trials place holder
place holder place holder

Clinical Trials

Clinical Laboratory Testing Volume 1: Reagents and Instruments


Publication Date   March 2007
Publisher   TriMark Publications
Product Type   Report
Pages   312
ISBN Number   TMRCLTV107-0301
Product Code   TRI068
Ask a question about this product?

Price £1,690.00

approximately: $3,158 | €2,143

Summary


Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large and diverse-crossing the $33 billion mark in 2006-and employing over 100,000 laboratory workers, and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory analysis usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The purpose of this report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this global clinical laboratory markets report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers' original equipment manufacturer (OEM) additional equipment. The emphasis in this analysis is on those companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent labs, physician's offices and miscellaneous clinics. This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world. The regional markets and their differences are examined, including Europe, Asia (Japan, China and India) and the rest of the world (ROW). Particular attention is paid to those areas of the clinical laboratory instrumentation and reagents sector that are showing the greatest growth or the most innovation.

Content


  • 1. Overview
    • 1.1 Objectives of the Report
    • 1.2 Methodology
    • 1.3 Scope of the Report
    • 1.4 Executive Summary
  • 2. IVD Clinical Laboratory Market
    • 2.1 Introduction
    • 2.2 Independent Clinical Labs
      • 2.2.1 Key Players for Independent Clinical Labs
      • 2.2.2 Quest and LabCorp
      • 2.2.3 Competitive Advantages at Quest and LabCorp
      • 2.2.4 Competitive Disadvantages of Quest and LabCorp
      • 2.2.5 Revenue Growth of Quest and LabCorp
      • 2.2.6 Sector Consolidation
      • 2.2.7 Additional Independent Clinical Laboratories
    • 2.3 Hospital Market
      • 2.3.1 Hospital Market Overview
      • 2.3.2 Hospital Lab Testing Drivers
      • 2.3.3 Evaluation Models of Laboratory Testing
      • 2.3.4 GPOs and IDNs
      • 2.3.5 Distributors
      • 2.3.6 Clinical Lab Testing Suppliers
      • 2.3.7 European Hospital Purchasing Practices
      • 2.3.8 Changes in Hospital Funding
      • 2.3.9 European Group Purchasing
    • 2.4 POL Market
    • 2.5 IVD Industry
      • 2.5.1 Industry Overview
      • 2.5.2 IVD Industry Leading Players Comparison and Review
      • 2.5.3 Biotechnology Reagents and Supplies
        • 2.5.3.1 Vendor Quality Assurance
        • 2.5.3.2 Partnership Support
        • 2.5.3.3 Protecting Supply of Raw Materials
        • 2.5.3.4 Selecting a Second Source for Chemicals
        • 2.5.3.5 Cost Analysis for Reagent Manufacture
        • 2.5.3.6 Outsourcing Production of Reagents
      • 2.5.4 The Fastest Growing IVD Reagent Markets
      • 2.5.5 Automated Instrumentation
      • 2.5.6 High Growth Applications Spur Industry Growth
    • 2.6 Automated Instrument Platforms Evolution
    • 2.7 Reagents and Supplies Market for Clinical Lab Instruments
    • 2.8 Spending for Clinical Laboratory Testing
      • 2.8.1 Reimbursement Pressure
      • 2.8.2 Medicare Part B Spending Trends
      • 2.8.3 Strategies for Revenue Growth
  • 3. IVD Clinical Laboratory Market
    • 3.1 Markets
      • 3.1.1 Global Markets
      • 3.1.2 Global Drivers of Clinical Laboratory Testing
      • 3.1.3 Global Outlook
      • 3.1.4 U.S. Market
      • 3.1.5 European IVD Market
        • 3.1.5.1 German Clinical Laboratory Diagnostic Markets
        • 3.1.5.2 U.K. Clinical Laboratory Testing Diagnostic Market
        • 3.1.5.2.1 U.K. Competitive Analysis
        • 3.1.5.2.2 U.K. Market Access
        • 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
        • 3.1.5.4 Italian Clinical Laboratory Diagnostic Market
        • 3.1.5.5 Spanish Clinical Laboratory Diagnostic Market
        • 3.1.5.6 Finnish Clinical Laboratory Market
        • 3.1.5.7 Turkish Clinical Laboratory Market
        • 3.1.5.8 Belgium Clinical Laboratory Diagnostic Market
        • 3.1.5.9 Swiss Clinical Laboratory Diagnostic Market
        • 3.1.5.10 Dutch Clinical Laboratory Diagnostic Market
        • 3.1.5.11 Portuguese Clinical Laboratory Diagnostic Market
        • 3.1.5.12 Austrian Clinical Laboratory Diagnostic Market
        • 3.1.5.13 Greek Clinical Laboratory Diagnostic Market
        • 3.1.5.14 Polish Clinical Laboratory Diagnostic Market
        • 3.1.5.15 Romanian Clinical Laboratory Diagnostic Market
        • 3.1.5.16 Czech Republic Clinical Laboratory Diagnostic Market
        • 3.1.5.17 Swedish Clinical Laboratory Diagnostic Market
        • 3.1.5.18 Norwegian Clinical Laboratory Diagnostic Market
        • 3.1.5.19 Irish Clinical Laboratory Diagnostic Market
        • 3.1.5.20 Hungarian Clinical Laboratory Diagnostic Market
        • 3.1.5.21 Bulgarian Clinical Laboratory Diagnostic Market
        • 3.1.5.22 Slovakian Clinical Laboratory Diagnostic Market
        • 3.1.5.23 Lithuanian Clinical Laboratory Diagnostic Market
        • 3.1.5.24 Latvian Clinical Laboratory Diagnostic Market
        • 3.1.5.25 Estonian Clinical Laboratory Diagnostic Market
        • 3.1.5.26 Slovenian Clinical Laboratory Diagnostic Market
      • 3.1.6 Asian Markets
        • 3.1.6.1 Indian Clinical Laboratory Diagnostic Market
        • 3.1.6.1.1 Indian IVD Testing Industry
        • 3.1.6.2 Japanese Clinical Laboratory Testing Market
        • 3.1.6.3 Chinese Clinical Laboratory Market
      • 3.1.7 Clinical Laboratory Smaller Country Markets
        • 3.1.7.1 Canadian Clinical Laboratory Market
        • 3.1.7.2 Brazilian Clinical Laboratory Market
        • 3.1.7.3 Australian Clinical Laboratory Market
      • 3.1.8 ROW Clinical Laboratory Testing Market
      • 3.1.9 Overview of Asian Healthcare Market
        • 3.1.9.1 Singapore
        • 3.1.9.2 Malaysia
        • 3.1.9.3 Thailand
        • 3.1.9.4 Indonesia
        • 3.1.9.5 Philippines
        • 3.1.9.6 South Korea
        • 3.1.9.7 India
        • 3.1.9.8 Hong Kong
        • 3.1.9.9 Taiwan
      • 3.1.10 Overview of the Latin American Diagnostics Market
    • 3.2 Clinical Laboratory Sector
      • 3.2.1 Worldwide IVD Sales
        • 3.2.1.1 POLs
      • 3.2.2 Industry Players
        • 3.2.2.1 Manufacturing Companies
      • 3.2.3 Market Specialization
      • 3.2.4 Revenue and Reimbursement
      • 3.2.5 Companies
    • 3.3 Outlook for Clinical Laboratory Testing
      • 3.3.1 Long-Term Changes
      • 3.3.2 Market Drivers
      • 3.3.3 The Limits to Growth
      • 3.3.4 Hot Sectors in the IVD Market
      • 3.3.5 Key Technologies
      • 3.3.6 Conclusion
  • 4. Clinical Laboratory Instrument Market by Sector
    • 4.1 Chemistry Analyzers
      • 4.1.1 Ultra-Large Throughput Laboratory Analyzers
      • 4.1.2 Large-Throughput Analyzers
      • 4.1.3 Mid-Size Clinical Laboratory Analyzers
      • 4.1.4 Laboratory Analyzers for the Small Volume Market
    • 4.2 Immunochemistry Analyzers
      • 4.2.1 Large Immunochemistry Analyzers
      • 4.2.2 Small Immunoassay Analyzers
    • 4.3 Hematology Analyzers
    • 4.4 POCT
      • 4.4.1 U.S. POC Markets
      • 4.4.2 European POCT Market
        • 4.4.2.1 German POC Diagnostic Markets
        • 4.4.2.2 U.K. POCT Diagnostic Market
        • 4.4.2.2.1 U.K. Market Statistics
        • 4.4.2.2.2 U.K. Competitive Analysis
        • 4.4.2.2.3 U.K. Market Access
        • 4.4.2.3 French POC Diagnostic Market
        • 4.4.2.4 Italian POC Diagnostic Market
        • 4.4.2.5 Spanish POC Diagnostic Market
        • 4.4.2.6 Scandinavian POC Market
      • 4.4.3 Japanese POCT Market
      • 4.4.4 Chinese POC Market
      • 4.4.5 Canadian POC Market
      • 4.4.6 Brazilian POC Market
      • 4.4.7 Turkish POC Market
      • 4.4.8 Australian POC Market
    • 4.5 ROW POCT Market
    • 4.6 Cytology Testing
    • 4.7 Microbiology Testing
    • 4.8 Serology Testing
    • 4.9 Esoteric Testing
    • 4.10 Anatomic Pathology
    • 4.11 Drug Testing
  • 5. Important Technology Trends in IVD Instrumentation and Reagents
    • 5.1 Technology Innovations in Instrument and Reagent Development
    • 5.2 Sensor Systems for Diagnostic Applications
    • 5.3 Glucose Measurements
    • 5.4 Glucose Test Methods
    • 5.5 Cholesterol Measurements
    • 5.6 The New Paradigm
    • 5.7 Consolidated Workstations
    • 5.8 Automation in the Laboratory
    • 5.9 Laboratory Information Systems
    • 5.10 New User-friendly Interfaces
    • 5.11 Biosensor Technology
    • 5.12 Data-Management Issues
      • 5.12.1 Wireless LANs
      • 5.12.2 Cepheid's POC GBS and BCR/ABL Tests
      • 5.12.3 Data and Workflow Management Systems
      • 5.12.4 Beckman Central Command
  • 6. Business Trends in the Clinical Laboratory Analyzer and Reagents Market
    • 6.1 Key Market Developments
      • 6.1.1 Decreasing Revenue from Traditional IVD Markets
      • 6.1.2 High Growth in POCT and Molecular Diagnostics Arena
      • 6.1.3 Move Away from Traditional Kit Testing Methods
      • 6.1.4 Integrated Analytical Systems
      • 6.1.5 Regulatory Changes
      • 6.1.6 Development of a Two-Tier Industry Structure
      • 6.1.7 Labor Costs
      • 6.1.8 Increasing Value of Companies with High-Margin Technology Platforms
      • 6.1.9 The Joining of IVD Testing and Computer Technology
      • 6.1.10 User-Friendly User Interfaces
    • 6.2 Sector Consolidation
      • 6.2.1 IVD Company Consolidation
      • 6.2.2 Lab Company Consolidation
        • 6.2.2.1 Acquisition Pricing
        • 6.2.2.2 A Closer Look at Six Big Lab Deals
    • 6.3 Diagnostic Testing Growth Trends
    • 6.4 Reagent and Hardware Business in Japan
    • 6.5 New Products
    • 6.6 Acquisition, License Agreements, Internal Development and Partnerships
    • 6.7 Product Testing Depth in Clinical Laboratory Testing
    • 6.8 Government Regulation of IVD Devices
      • 6.8.1 U.S. Regulation
        • 6.8.1.1 Importing Medical Devices into the U.S.
        • 6.8.1.2 Exporting Medical Devices from the U.S.
      • 6.8.2 U.K. Regulation
      • 6.8.3 E.U. Regulation
        • 6.8.3.1 France
      • 6.8.4 Japanese Regulation
      • 6.8.5 Korean Regulation
      • 6.8.6 Chinese Regulation
    • 6.9 Increased Market Penetration
    • 6.10 Costs of Doing Business in Europe
    • 6.11 Drivers of European Diagnostics Testing
    • 6.12 European Reimbursement Practices
    • 6.13 Cost Containment in Europe
    • 6.14 Hospital Outreach Programs
    • 6.15 Electronic Procurement: New Challenges
    • 6.16 Competition for Supply Chain Management Solutions
    • 6.17 E-Commerce in the Hospital Supply Chain
      • 6.17.1 Drivers of E-Commerce Solutions
      • 6.17.2 Barriers to E-Commerce Solutions
    • 6.18 Top Trends in Laboratory Business Practices
    • 6.19 The Value of the New Diagnostics
    • 6.20 Converging Technologies-Drugs and Diagnostic Tests Combine for Improved Healthcare
    • 6.21 Emerging Technologies in the Downstream Manufacture of Bio-Materials
    • 6.22 GMP Readiness
    • 6.23 Harnessing Human Resource Capabilities and IT Prowess: Biotechnology in the Future
    • 6.24 Partnering with Patient-Based Organizations to Achieve Patient Health Goals
    • 6.25 Rumors of the Platform Company's Demise are Greatly Exaggerated
    • 6.26 Who's Going to Pay for It?
  • 7. Company Profiles
    • 7.1 Abaxis
    • 7.2 Abbott Diagnostics
    • 7.3 Adaltis, Inc.
    • 7.4 Alfa Wasserman, Inc. (formerly Electro-Nucleonics, Inc. and Schiapparelli Biosystems, Inc.)
    • 7.5 Awareness Technology
    • 7.6 Bayer Diagnostics
    • 7.7 Beckman Coulter, Inc.
    • 7.8 Bio-Reference Laboratories, Inc.
    • 7.9 Clarient, Inc.
    • 7.10 Dade Behring, Inc.
    • 7.11 Enzo Biochem, Inc.
    • 7.12 Genomic Health, Inc.
    • 7.13 Hitachi
    • 7.14 Horiba Ltd.
    • 7.15 JEOL Ltd.
    • 7.16 LabCorp
    • 7.17 Medtox Scientific, Inc.
    • 7.18 Monogram Biosciences, Inc.
    • 7.19 Myriad Genetics, Inc.
    • 7.20 Nova Biomedical
    • 7.21 Olympus America, Inc. Diagnostic Systems Division
    • 7.22 Ortho-Clinical Diagnostics, a J&J Company
    • 7.23 Psychemedics Corporation
    • 7.24 Quest Diagnostics, Inc.
    • 7.25 Roche Diagnostics Corp.
    • 7.26 Shimadzu
    • 7.27 Sysmex Corporation
    • 7.28 Thermo Fisher Scientific, Inc.
    • 7.29 Vital Scientific, NV
  • List Of Figures
    • Figure 2.1: Clinical Laboratory Testing Sector Providers
    • Figure 2.2: Part B Spending on Clinical Laboratory Services, 1991-2005
    • Figure 3.1: European IVD Market by Clinical Specialty
    • Figure 3.2: Chinese IVD Market, 1995-2004
    • Figure 3.3: Annual Worldwide IVD Market Growth, 2003-2005
    • Figure 3.4: POL Revenue, 2000-2006
    • Figure 3.5: Unweighted Average Medicare Reimbursement for Ten Most Common POL Tests, 2002 vs. 2006
    • Figure 3.6: Total Number of Non-Waived POLs, 2000-2006
    • Figure 3.7: Number of New Tests Granted CLIA-Waived Status, 2000-2006
    • Figure 3.8: High-Volume Waived Tests
    • Figure 3.9: U.S. Revenue for Six Largest IVD Vendors, 2005
    • Figure 3.10: U.S. Revenue Change for Six Largest IVD Vendors, 2005
    • Figure 6.1: Average Revenue-Multiple Paid to Acquire Labs, 2000-2006
    • Figure 6.2: Hospital Market Share for Outreach Programs
  • List Of Tables
    • Table 2.1: Total U.S. Clinical Laboratory Revenue from Third Party and Direct Payment, 2005-2012
    • Table 2.2: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2005
    • Table 2.3: Independent Commercial Laboratory Testing Market Value, 2005-2012
    • Table 2.4: Independent Commercial Laboratory Testing Test Volume, 2005-2012
    • Table 2.5: Leading U.S. Reference Laboratories Grouped by Market Capitalization, 2006
    • Table 2.6: Revenue Growth at Quest Diagnostics, 2000-2006
    • Table 2.7: Revenue Growth at LabCorp, 2000-2006
    • Table 2.8: Quest Diagnostics Revenue from Managed Care Contracts, 2004-2006
    • Table 2.9: LabCorp Revenue from Managed Care Contracts, 2004-2006
    • Table 2.10: Quest's Total Volume of Requisitions and Net Revenues from Clinical Laboratory Testing, 2005
    • Table 2.11: Number of Hospital Based Clinical Laboratory Tests in the U.S., 2002-2008
    • Table 2.12: European Cardiovascular Disease Management Expenditures, 2003-2010
    • Table 2.13: U.S. Doctor's Office Lab Test Dollar Volume and Growth Rates, 2006
    • Table 2.14: Worldwide Alternate Site Clinical Lab Instrument and Reagents Sales, 2005-2012
    • Table 2.15: Top IVD Manufacturers, 2005
    • Table 2.16: Products Marketed by Abbott in the Diagnostic Market
    • Table 2.17: Prodesse's ASRs
    • Table 2.18: Hospital Laboratory Share of Part B Medicare Spending, 1996-2005
    • Table 2.19: Medicare Spending on Clinical Lab Services, 1991-2005
    • Table 2.20: Medicare Part B Spending Per Medicare Enrollee, 1998-2005
    • Table 2.21: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2005
    • Table 3.1: Worldwide IVD Testing Market, 2006
    • Table 3.2: Worldwide Distribution of IVD Testing, 2006
    • Table 3.3: Global Clinical Laboratory Market Sales, 1998-2010
    • Table 3.4: Top 15 IVD Manufacturers' Worldwide Revenue
    • Table 3.5: U.S. Clinical Laboratory Testing Market, 2003-2012
    • Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2006
    • Table 3.7: U.S. Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by Analyte, 2006
    • Table 3.8: U.S. Individual Clinical Chemistry Laboratory Diagnostic Test Markets, 2006
    • Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
    • Table 3.10: European Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by Analyte, 2006
    • Table 3.11: European Clinical Chemistry Testing Reagents and Instruments Market, 2006
    • Table 3.12: European Clinical Laboratory Testing Diagnostics by Country Market, 2006
    • Table 3.13: European Rapid POCT by Country Market, 2006
    • Table 3.14: European Patient Self Testing OTC Diagnostics by Country Market, 2006
    • Table 3.15: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003-2012
    • Table 3.16: German Clinical Reagents and Instruments Market, 2003
    • Table 3.17: U.K. Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.18: U.K. Clinical Reagents and Instruments Market, 2006
    • Table 3.19: Major U.K. IVD Manufacturers
    • Table 3.20: U.S. IVD Manufacturers Doing Business in the U.K.
    • Table 3.21: Other European Companies that Manufacture IVD Products in the U.K.
    • Table 3.22: French Clinical IVD Testing Diagnostics Products Market Sales, 2003-2012
    • Table 3.23: French Clinical Reagents and Instruments Market, 2006
    • Table 3.24: Italian Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.25: Italian Clinical Reagents and Instruments Market, 2006
    • Table 3.26: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.27: Spanish Clinical Reagents and Instruments Market, 2006
    • Table 3.28: Finnish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.29: Finnish Clinical Reagents and Instruments Market, 2006
    • Table 3.30: Turkish Clinical Laboratory Testing Market, 2003-2012
    • Table 3.31: Belgium Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.32: Belgium Clinical Reagents and Instruments Market, 2006
    • Table 3.33: Swiss Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.34: Swiss Clinical Reagents and Instruments Market, 2006
    • Table 3.35: Dutch Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.36: Dutch Clinical Reagents and Instruments Market, 2006
    • Table 3.37: Portuguese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.38: Portuguese Clinical Reagents and Instruments Market, 2006
    • Table 3.39: Austrian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.40: Austrian Clinical Reagents and Instruments Market, 2006
    • Table 3.41: Greek Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.42: Greek Clinical Reagents and Instruments Market, 2006
    • Table 3.43: Polish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.44: Polish Clinical Reagents and Instruments Market, 2006
    • Table 3.45: Romanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.46: Romanian Clinical Reagents and Instruments Market, 2006
    • Table 3.47: Czech Republic Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.48: Swedish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.49: Norwegian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.50: Irish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.51: Hungarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.52: Bulgarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.53: Slovakian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.54: Lithuanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.55: Latvian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.56: Estonian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.57: Slovenian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.58: Indian IVD Market for Instruments and Reagents, 2004-2012
    • Table 3.59: Number of Automated Clinical Labs in India, 2004-2012
    • Table 3.60: Indian IVD Market, 2006
    • Table 3.61: Market Sales of IVD Equipment and Reagents by Company in India, 2004 and 2005
    • Table 3.62: Japanese Clinical Laboratory Testing Instrument and Reagents Market, 2003-2012
    • Table 3.63: Chinese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
    • Table 3.64: Chinese IVD Market
    • Table 3.65: Proportion of Medical Expenses Paid Privately
    • Table 3.66: Chinese International IVD Manufacturers
    • Table 3.67: Chinese Domestic IVD Manufacturers
    • Table 3.68: Chinese IVD Distributors
    • Table 3.69: Canadian Clinical Laboratory Testing Market, 2000-2008
    • Table 3.70: Brazilian Clinical Laboratory Testing Market, 2000-2008
    • Table 3.71: Australian Clinical Laboratory Testing Market, 2000-2008
    • Table 3.72: ROW Clinical Laboratory Testing Market, 2000-2008
    • Table 3.73: Number of Clinical Laboratories in Latin America
    • Table 3.74: Twenty Most Common Laboratory Tests Offered at Family Physician Offices
    • Table 3.75: Important New Waived Tests
    • Table 3.76: Principal Marketers of Automated Clinical Laboratory Instruments
    • Table 4.1: Ultra-Large Clinical Laboratory Analyzers
    • Table 4.2: JEOL Analyzer Comparison
    • Table 4.3: Large Clinical Laboratory Analyzers
    • Table 4.4: Mid-size Clinical Laboratory Analyzers
    • Table 4.5: Small Clinical Laboratory Analyzers
    • Table 4.6: Large Immunochemistry Analyzers
    • Table 4.7: Small Immunoassay Analyzers
    • Table 4.8: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers
    • Table 4.9: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers
    • Table 4.10: Linearity and Precision of Bayer Hematology Analyzers
    • Table 4.11: Accuracy of the Automated Differential of Bayer Hematology Analyzers
    • Table 4.12: Linearity and Precision of Beckman Coulter Hematology Instruments
    • Table 4.13: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers
    • Table 4.14: Linearity and Precision of Horiba ABX Hematology Analyzers
    • Table 4.15: Accuracy of the Horiba ABX Hematology Analyzers
    • Table 4.16: Linearity and Precision of Sysmex Hematology Analyzers
    • Table 4.17: Accuracy of the Sysmex Hematology Analyzers
    • Table 4.18: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers
    • Table 4.19: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers
    • Table 4.20: Hematology Analyzers with a Five-Part WBC Differential
    • Table 4.21: Hematology Analyzers with a Three-Part WBC Differential
    • Table 4.22: POCT
    • Table 4.23: Number of ER Visits in U.S. Hospitals, 1996-2005
    • Table 4.24: Number of POCT in U.S., 2000-2011
    • Table 4.25: Global POC Revenues, 1998-2008
    • Table 4.26: Worldwide Distribution of POCT, 2005
    • Table 4.27: U.S. POCT Market, 2000-2011
    • Table 4.28: U.S. Clinical Diagnostic Test Market Segments, Revenue from Clinical Laboratory Testing, 2005
    • Table 4.29: U.S. POCT by Distribution Location, 2005
    • Table 4.30: U.S. Clinical Diagnostic POCT and Rapid Test Market Segments, 2005
    • Table 4.31: Drivers of European Diagnostics Testing
    • Table 4.32: Regional Comparison of Healthcare and IVD for Eastern Europe
    • Table 4.33: European IVD Reagent Testing Market, 2000-2012
    • Table 4.34: European Testing Diagnostics Market, 2004
    • Table 4.35: Top Dozen Country IVD Testing Markets and POC Share, 2004
    • Table 4.36: German POCT Diagnostics Products Market Sales, 2002-2007
    • Table 4.37: German Patient Care Central Lab Test Market, 2000-2008
    • Table 4.38: German Alternate Site Testing Market (POL), 2000-2008
    • Table 4.39: German Hospital POC Market, 2000-2008
    • Table 4.40: German Clinical Diagnostic Test Market Segments; Sales from Clinical Laboratory Testing, 2004
    • Table 4.41: German Clinical Diagnostic Rapid Test Market Segments
    • Table 4.42: U.K. POC Diagnostics Products Market Sales, 1998-2007
    • Table 4.43: Major U.K. IVD Manufacturers
    • Table 4.44: U.S. IVD Manufacturers Doing Business in the U.K.
    • Table 4.45: Other European Companies that Manufacture IVD Products in the U.K.
    • Table 4.46: French POC Diagnostics Products Market Sales, 1998-2007
    • Table 4.47: Italian POC Diagnostics Products Market Sales, 1998-2007
    • Table 4.48: Spanish POC Diagnostics Products Market Sales, 1998-2007
    • Table 4.49: Scandinavian POC Diagnostics Products Market Sales, 2000-2008
    • Table 4.50: Japanese POCT Market, 2000-2008
    • Table 4.51: Chinese POC Diagnostics Products Market Sales, 2000-2008
    • Table 4.52: Canadian POCT Market, 2000-2008
    • Table 4.53: Brazilian POCT Market, 2000-2008
    • Table 4.54: Turkish POCT Market, 2000-2008
    • Table 4.55: Australian POCT Market, 2000-2008
    • Table 4.56: ROW POCT Market, 2000-2007
    • Table 4.57: PAP Tests in Top European Markets
    • Table 4.58: PAP Tests in Top Asian Markets
    • Table 5.1: Normal Glucose Values-Fasting State
    • Table 5.2: Applications for Wireless LAN Technology
    • Table 7.1: Products Marketed by Abbott in the Diagnostics Market
    • Table 7.2: Products Marketed by Dade Behring in the Diagnostics Market
    • Table 7.3: Clinically Significant Tests Available From Dade
    • Table 7.4: Comparison of JEOL Analyzers
    • Table 7.5: The VITROS ECiQ Immunodiagnostic System
    • Table 7.6: Sysmex Marketing Summary for China